IP Library Granted Patent US 10,384,972
Granted Patent B2
US 10,384,972 · App. 14/174,439 · Granted Aug 20, 2019

Fused quartz tubing for pharmaceutical packaging and methods for making the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,384,972
App. No.
14/174,439
Granted
Aug 20, 2019
Kind
B2
Abstract

A method for forming high purity silica articles. The high purity silica articles can be particularly suitable for forming packaging such as packaging for pharmaceutical applications. The method for forming high purity silica articles can comprise, in one embodiment, (a) forming a fused quartz melt from a SiO 2 raw material; (b) forming a quartz tube from the fused quartz melt; (c) treating the quartz tube with an acid composition; (d) heat treating the quartz tube subsequent to treating with the acid composition; and (e) optionally treating the quartz article with an acid composition subsequent to the heat treating operation. The method can enhance the purity of silica glass articles and products made therefrom.

Claims (42)

1. A method of forming an article comprising high purity fused silica comprising:

(a) heating a raw material comprising SiO 2 to form a fused quartz melt;

(b) forming a quartz glass tube from the fused quartz melt;

(c) treating the quartz glass tube from (b) with a composition comprising an acid followed by a water rinse to remove the acid from the glass tube;

(d) heat treating the quartz glass tube from (c) at a temperature of from about 900° C. to about 1250° C.; and

(e) converting the quartz glass tube into a pharmaceutical package via thermal processing, wherein the article has a surface glass test result equal to or less than 0.10 ml of 0.01M HCl per 100 ml of test solution according to the USP<660> surface glass test.

2. The method of claim 1 , wherein the acid comprises an acid chosen from hydrofluoric acid, hydrochloric acid, hydrogen bifluoride, ammonium bifluoride, nitric acid, phosphoric acid, or a combination of two or more thereof.

3. The method of claim 1 , wherein treating with the composition comprising the acid is conducted at a temperature of from about 10° C. to about 100° C.

4. The method of claim 1 , wherein the treating operation (c) comprises agitating the acid composition and/or the quartz glass tube.

5. The method of claim 1 , wherein the treating operation (c) is conducted two or more times with or without other process steps in between, and the quartz glass tube is washed with water subsequent to each treating operation (c).

6. The method of claim 1 , wherein step (e) further comprises:

cutting the quartz glass tube subsequent to operation (d) to form cut quartz glass sections; and

washing the cut quartz glass sections with an acid composition followed by a water rinse.

7. The method of claim 6 , wherein the acid composition comprises an acid chosen from hydrofluoric acid, hydrochloric acid, hydrogen bifluoride, ammonium bifluoride, nitric acid, phosphoric acid, or a combination of two or more thereof.

8. The method of claim 1 , wherein the article has a SiO 2 concentration of about 99% or greater.

9. The method of claim 1 , wherein the surface glass test result is equal to or less than 0.025 of 0.01 M HCl per 100 ml of test solution.

10. A method of forming a pharmaceutical package comprising:

(A) providing quartz glass tube having a SiO 2 concentration of about 99% or greater, the quartz glass tube being produced by a process comprising:

(i) heating a raw material comprising SiO 2 to form a fused quartz melt;

(ii) forming a quartz glass tube from the fused quartz melt;

(iii) treating the quartz glass tube from (A)(ii) with a composition comprising an acid followed by a water rinse to remove the acid, and

(iv) heat treating the quartz glass tube following (A)(iii);

(v) cutting the quartz glass tube to desired lengths suited for pharmaceutical packaging; and

(B) converting the quartz glass tube into a pharmaceutical package via thermal processing, wherein the package has a surface glass test result equal to or less than 0.10 ml of 0.01M HCl per 100 ml of test solution according to the USP<660> surface glass test.

11. The method of claim 10 , wherein converting the quartz glass tube into a pharmaceutical package comprises converting the tube into a package in the form of a vial, an ampoule, or a syringe.

12. The method of claim 10 , wherein the treating operation (iii) is conducted at a temperature of from about 10° C. to about 100° C.

13. The method of claim 10 , wherein the treating operation (iii) comprises agitating the composition comprising the acid and/or the quartz glass tube.

14. The method of claim 10 , wherein the treating operation (iii) is conducted two or more times, with or without other process steps in between, and the quartz glass tube is washed with water subsequent to each treating operation.

15. The method of claim 10 , wherein the heat treating operation (iv) comprises heating at a temperature of from about 900° C. to about 1250° C. at a pressure of about 10 torr or less.

16. A method forming a pharmaceutical package from an article comprising a high purity silica, the method comprising;

(a) heating a SiO 2 raw material having a SiO 2 concentration of about 99% or greater at a temperature of from about 2000° C. to about 3000° C. to form a fused quartz material;

(b) drawing the fused quartz material to form a quartz tube;

(c) treating the quartz tube from (b) with an acid composition at a temperature of from about 10° C. to about 100° C.;

(d) washing the quartz tube treated in (c) with water to remove the acid from (c);

(e) heating the quartz tube from (d) at a temperature of from about 900° C. to about 1250° C. and a pressure of 10 torr or less; and

(f) converting the quartz tube into a pharmaceutical package via thermal processing, wherein the article has a surface glass test result equal to or less than 0.10 ml of 0.01M HCl per 100 ml of test solution according to the USP<660> surface glass test.

17. The method of claim 16 , wherein the acid composition comprises an acid chosen from hydrofluoric acid, hydrochloric acid, nitric acid, hydrogen bifluoride, ammonium bifluoride, phosphoric acid, or a combination of two or more thereof.

18. The method of claim 16 , further comprising:

(f) cutting the quartz tube subsequent to operation (e) to form cut quartz glass sections; and

(g) washing the cut quartz glass sections with an acid composition followed by a water rinse.

19. The method of claim 16 , wherein the treating operation comprises agitating the acid composition and/or quartz tube.

20. The method of claim 16 , comprising drying the quartz tube following the washing operation (d).

Assignments (14)
PATENT SECURITY AGREEMENT Recorded May 23, 2025
From: MOMENTIVE PERFORMANCE MATERIALS QUARTZ, INC.
To: STANDARD CHARTERED BANK, AS COLLATERAL AGENT AND ADMINISTRATIVE AGENT
Reel/Frame 071368/0854 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 31, 2023
From: BNP PARIBAS
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 063259/0133 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2023
From: KOOKMIN BANK NEW YORK
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 063197/0373 →
NUNC PRO TUNC ASSIGNMENT Recorded Feb 4, 2021
From: MOMENTIVE PERFORMANCE MATERIALS INC.
To: MOMENTIVE PERFORMANCE MATERIALS QUARTZ, INC.
Reel/Frame 055222/0140 →
FIRST LIEN TERM LOAN PATENT AGREEMENT Recorded Jun 5, 2019
From: MOMENTIVE PERFORMANCE MATERIALS INC.
To: BNP PARIBAS, AS ADMINISTRATIVE AGENT
Reel/Frame 049387/0782 →
ABL PATENT AGREEMENT Recorded Jun 5, 2019
From: MOMENTIVE PERFORMANCE MATERIALS INC.; MOMENTIVE PERFORMANCE MATERIALS GMBH
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049388/0252 →
SECOND LIEN TERM LOAN PATENT AGREEMENT Recorded Jun 5, 2019
From: MOMENTIVE PERFORMANCE MATERIALS INC.
To: KOOKMIN BANK, NEW YORK BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 049388/0220 →
RELEASE OF SECURITY INTEREST Recorded May 15, 2019
From: BOKF, NA
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 049249/0271 →
RELEASE OF SECURITY INTEREST Recorded May 15, 2019
From: BOKF, NA
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 049194/0085 →
NOTICE OF CHANGE OF COLLATERAL AGENT - ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY - SECOND LIEN Recorded Mar 6, 2015
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. AS COLLATERAL AGENT
To: BOKF, NA, AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 035137/0263 →
NOTICE OF CHANGE OF COLLATERAL AGENT - ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Mar 6, 2015
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. AS COLLATERAL AGENT
To: BOKF, NA, AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 035136/0457 →
SECURITY INTEREST Recorded Oct 27, 2014
From: MOMENTIVE PERFORMANCE MATERIALS INC.
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS COLLATERAL AGENT
Reel/Frame 034066/0662 →
SECURITY INTEREST Recorded Oct 27, 2014
From: MOMENTIVE PERFORMANCE MATERIALS INC.
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS COLLATERAL AGENT
Reel/Frame 034066/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2014
From: XU, GUANGJUN; KOCH, ROBERT
To: MOMENTIVE PERFORMANCE MATERIALS INC.
Reel/Frame 032520/0980 →